相关实验视频
Updated: Sep 12, 2025
08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
12.9K
银二胺化物在老年人中的临床使用:范围审查
Alice Kit Ying Chan1, Stephanie Chu1, Ollie Yiru Yu1
1Faculty of Dentistry, The University of Hong Kong, 3/F, The Prince Philip Dental Hospital, 34, Hospital Road, Sai Ying Pun, Hong Kong, China.
Journal of dentistry
|August 4, 2025
概括
银胺化物 (SDF) 对老年人来说是有前途的,有效地治疗,减少斑块和缓解过敏症. 需要进一步的研究来证实长期的好处和安全性在这个人口.
科学领域:
- 老年人牙科 老年人牙科
- 皮肤病学 皮肤病学 皮肤病学
- 预防性牙科 预防性牙科
背景情况:
- 银二胺化物 (SDF) 已被确立用于早期儿童虫管理.
- 它在老年人中的应用和有效性不太清楚.
研究的目的:
- 对65岁以上的成年人进行SDF临床证据的范围审查.
- 综合SDF对老年人口口腔健康结果的影响的研究结果.
主要方法:
- 在 Embase,PubMed,Scopus 和 Web of Science 的系统搜索.
- 包括2025年6月30日之前的英语临床研究.
- 两个独立的研究人员进行了研究选择.
主要成果:
- 九项研究评估了SDF的,牙炎症和过敏性.
- 在阻止 (高达86%) 和预防根病方面,SDF表现出有效性.
- 研究表明,与对照组相比,SDF减少了斑块,牙炎症和过敏症.
结论:
- 在老年人中,SDF显示出治疗虫,减少斑块和缓解过敏症的潜力.
- 有限的证据需要进一步严格的试验来确定长期的结果和安全性.
- 研究重点包括长期疗效,不良反应和特定年龄段的治疗方案.
相关概念视频
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669